Affordable Access

deepdyve-link
Publisher Website

KRAS mutations: Analytical considerations

Authors
  • Herreros-Villanueva, Marta
  • Chen, Chih-Chieh
  • Yuan, Shyng-Shiou F.
  • Liu, Ta-Chih
  • Er, Tze-Kiong1, 2, 3, 4, 5, 6, 7, 8, 9, 6, 10, 11, 6, 10, 12, 13, 6, 14, 15, 10, 16, 17, 6
  • 1 Department of Gastroenterology
  • 2 Hospital Donostia/Instituto Biodonostia
  • 3 Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd)
  • 4 Universidad del País Vasco UPV/EHU
  • 5 Center for Lipid Biosciences
  • 6 Kaohsiung Medical University Hospital
  • 7 Biomedical Technology and Device Research Laboratories
  • 8 Industrial Technology Research Institute
  • 9 Department of Medical Research
  • 10 Kaohsiung Medical University
  • 11 Translational Research Center
  • 12 Division of Hematology and Oncology
  • 13 Department of Internal Medicine
  • 14 Institute of Clinical Medicine
  • 15 College of Medicine
  • 16 Division of Molecular Diagnostics
  • 17 Department of Laboratory Medicine
Type
Published Article
Journal
Clinica Chimica Acta
Publisher
Elsevier
Publication Date
Jan 01, 2014
Accepted Date
Jan 22, 2014
Volume
431
Pages
211–220
Identifiers
DOI: 10.1016/j.cca.2014.01.049
Source
Elsevier
Keywords
License
Unknown

Abstract

•We review the latest published literature specific to KRAS mutation testing techniques.•Reliability and feasibility are important issues in clinical analyses.•We summarize the effectiveness and limitations of numerous KRAS mutation testing techniques

Report this publication

Statistics

Seen <100 times